impact factor
logo
 

Letter

 

Type II cryoglobulinaemic vasculitis with primary Sjögren's syndrome successfully treated with belimumab and hydroxychloroquine


1, 2, 3, 4

 

  1. Division of Rheumatic Diseases, National Center for Global Health and Medicine, Shinjuku, Tokyo, Japan. cmt3cts@gmail.com
  2. Division of Rheumatic Diseases, National Center for Global Health and Medicine, Shinjuku, Tokyo, Japan.
  3. Division of Rheumatic Diseases, National Center for Global Health and Medicine, Shinjuku, Tokyo, Japan.
  4. Division of Rheumatic Diseases, National Center for Global Health and Medicine, Shinjuku, Tokyo, Japan.

CER14485
Letter

Free to view
(click on article PDF icon to read the article)

PMID: 33666157 [PubMed]

Received: 03/02/2021
Accepted : 01/03/2021
In Press: 04/03/2021

Rheumatology Article